Related references
Note: Only part of the references are listed.Tumor Response Assessment in Diffuse Intrinsic Pontine Glioma: Comparison of Semiautomated Volumetric, Semiautomated Linear, and Manual Linear Tumor Measurement Strategies
L. A. Gilligan et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2020)
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
Michael Karremann et al.
NEURO-ONCOLOGY (2018)
Targeted Therapy for Premenopausal Women with HR+, HER2- Advanced Breast Cancer: Focus on Special Considerations and Latest Advances
Aditya Bardia et al.
CLINICAL CANCER RESEARCH (2018)
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
Lindsey M. Hoffman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger et al.
CLINICAL CANCER RESEARCH (2017)
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
David A. Solomon et al.
BRAIN PATHOLOGY (2016)
Targeting CDK4 and CDK6: From Discovery to Therapy
Charles J. Sherr et al.
CANCER DISCOVERY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas
Jeffrey R. Infante et al.
CLINICAL CANCER RESEARCH (2016)
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics
Lindsey M. Hoffman et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Pubertal Development and Primary Ovarian Insufficiency in Female Survivors of Embryonal Brain Tumors Following Risk-Adapted Craniospinal Irradiation and Adjuvant Chemotherapy
Mariko DeWire et al.
PEDIATRIC BLOOD & CANCER (2015)
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz et al.
NATURE GENETICS (2014)
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Kathryn R. Taylor et al.
NATURE GENETICS (2014)
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Adam M. Fontebasso et al.
NATURE GENETICS (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
M. H. A. Jansen et al.
CANCER TREATMENT REVIEWS (2012)
Development of six PROMIS pediatrics proxy-report item banks
Debra E. Irwin et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2012)
Clinical Stratification of Glioblastoma Based on Alterations in Retinoblastoma Tumor Suppressor Protein (RB1) and Association With the Proneural Subtype
Patricia Goldhoff et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma
Jacques Grill et al.
PEDIATRIC BLOOD & CANCER (2012)
Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma
Barbara S. Paugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Brain Tumors Across the Age Spectrum: Biology, Therapy, and Late Effects
Thomas E. Merchant et al.
SEMINARS IN RADIATION ONCOLOGY (2010)
Ovarian Failure and Reproductive Outcomes After Childhood Cancer Treatment: Results From the Childhood Cancer Survivor Study
Daniel M. Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
Gregory T. Armstrong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Cancer Survivorship: A Pediatric Perspective
Wendy Landier et al.
ONCOLOGIST (2008)
Endocrine late effects of childhood cancer therapy: A report from the children's oncology group
Radha Nandagopal et al.
HORMONE RESEARCH (2008)
Cyclin-dependent kinase pathways as targets for cancer treatment
GI Shapiro
JOURNAL OF CLINICAL ONCOLOGY (2006)
Diffuse brainstem glioma in children: critical review of clinical trials
D Hargrove et al.
LANCET ONCOLOGY (2006)
Fertility preservation for young patients with cancer: who is at risk and what can be offered?
WHB Wallace et al.
LANCET ONCOLOGY (2005)
Growth and endocrine function after chemotherapy and radiotherapy in childhood
HA Spoudeas
EUROPEAN JOURNAL OF CANCER (2002)
Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function
TE Merchant et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors
KE Warren et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
